SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-501623"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-501623" > Risk and location o...

Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial

Bahadoer, Renu R. (författare)
Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
Hospers, Geke A. P. (författare)
Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.;Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.
Marijnen, Corrie A. M. (författare)
Netherlands Canc Inst, Dept Radiat Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.;Leiden Univ, Dept Radiat Oncol, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
visa fler...
Peeters, Koen C. M. J. (författare)
Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
Putter, Hein (författare)
Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
Dijkstra, Esmee A. (författare)
Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.
Kranenbarg, Elma Meershoek-Klein (författare)
Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
Roodvoets, Annet G. H. (författare)
Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
van Etten, Boudewijn (författare)
Univ Med Ctr Groningen, Dept Surg, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.
Nilsson, Per J. (författare)
Karolinska Institutet
Glimelius, Bengt (författare)
Uppsala universitet,Cancerprecisionsmedicin
van de Velde, Cornelis J. H. (författare)
Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands.
, ollaborative investigators (författare)
visa färre...
Leiden Univ, Dept Surg, Med Ctr, Albinusdreef 2,Postbus 9600, NL-2300 RC Leiden, Netherlands Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands.;Univ Med Ctr Groningen, Dept Med Oncol, Hanzepl 1,Postbus 30-001, NL-9700 RB Groningen, Netherlands. (creator_code:org_t)
Elsevier, 2023
2023
Engelska.
Ingår i: European Journal of Cancer. - : Elsevier. - 0959-8049 .- 1879-0852. ; 185, s. 139-149
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Introduction: Although optimising rectal cancer treatment has reduced local recurrence rates, many patients develop distant metastases (DM). The current study investigated whether a total neoadjuvant treatment strategy influences the development, location, and timing of metastases in patients diagnosed with high-risk locally advanced rectal cancer included in the Rectal cancer And Pre-operative Induction therapy followed by Dedicated Operation (RAPIDO) trial.Material and methods: Patients were randomly assigned to short-course radiotherapy fol-lowed by 18 weeks of CAPOX or FOLFOX4 before surgery (EXP), or long-course che-moradiotherapy with optional postoperative chemotherapy (SC-G). Assessments for metastatic disease were performed pre-and post-treatment, during surgery, and 6, 12, 24, 36, and 60 months postoperatively. From randomisation, differences in the occurrence of DM and first site of metastasis were evaluated.Results: In total, 462 patients were evaluated in the EXP and 450 patients in the SC-G groups. The cumulative probability of DM at 5 years after randomisation was 23% [95% CI 19-27] and 30% [95% CI 26-35] (HR 0.72 [95% CI 0.56-0.93]; P = 0.011) in the EXP and SC -G, respectively. The median time to DM was 1.4 (EXP) and 1.3 years (SC-G). After diagnosis of DM, median survival was 2.6 years [95% CI 2.0-3.1] in the EXP and 3.2 years [95% CI 2.3-4.1] in the SC-G groups (HR 1.39 [95% CI 1.01-1.92]; P = 0.04). First occurrence of DM was most often in the lungs (60/462 [13%] EXP and 55/450 [12%] SC-G) or the liver (40/462 [9%] EXP and 69/450 [15%] SC-G). A hospital policy of postoperative chemotherapy did not influence the development of DM.Conclusions: Compared to long-course chemoradiotherapy, total neoadjuvant treatment with short-course radiotherapy and chemotherapy significantly decreased the occurrence of me-tastases, particularly liver metastases.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)

Nyckelord

Rectal cancer
Total neoadjuvant therapy
Distant metastases
Metastatic pattern

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy